Authors
Latest:
New Therapeutics Treat Homologous Recombination Repair DeficiencyUnderstanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.
Latest:
Wearable Wrist Monitoring Devices Can Improve Atrial Fibrillation OutcomesThe use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
Latest:
A New Frontier in the Fight Against Rare DiseaseRare disease specialty pharmacies offer customizable pharmacy and patient services to make it easier for people living with rare, complex, and often isolating conditions to access the therapy, care, and resources they need.
Latest:
Developing and Implementing Immunization Standing Orders and ProtocolsVaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
Latest:
Actionable Mutations in Hematologic MalignanciesThe use of high throughput technologies has revolutionized the understanding of the cancer genome.
Latest:
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional CareStudents are being exposed to new patient experiences through collaboration with practitioners.
Latest:
Focus on Multiple Sclerosis: Benefits of Advanced Pharmacist Certification, a Glimpse into the Drug PipelinePharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Latest:
Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health OutcomesAdditional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Latest:
Summer Skincare: Sunburn and Allergic Contact DermatitisPatients may consult with their pharmacist regarding appropriate protection methods and treatment options available for common summer skin ailments.
Latest:
The Evolution of Biologics and Biosimilars: Reducing Costs and Improving Accessibility Through Pharmacist EngagementOriginal biologic products, and more recently biosimilar products, are a groundbreaking advancement in modern medical treatments. Pharmacists should understand biologic products and concerns with biosimilars.
Latest:
The Art of ART: The Pharmacist’s Role in HIV CarePharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.
Latest:
Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRIDistinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.
Latest:
Outlook for Health System-Based Specialty Pharmacy in 2022 and BeyondWith integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
When It Comes to Curbing Drug Abuse, Technicians Are CrucialAdequate training will help them recognize signs of misuse and assist with preventive measures.
Latest:
Pharmacy Care Management Can Address the Challenges of an Evolving Health Care LandscapeWhen pharmacists are involved in the care process, they can address common barriers to medication use, such as polypharmacy, ineffective medication, high costs, health and lifestyle considerations, and social needs.
Latest:
Pharmacists: Pioneers of Inpatient Medication SafetyImproving patient safety and reducing harmful events is a team effort that includes both executive leadership and management as well as front line care teams.
Latest:
A Pharmacist’s Guide to the Management of Polycystic Ovarian SyndromePharmacists play an important role in managing patients with this complex condition.
Latest:
How Pharmacists Can Help Patients With Bipolar Disorder Make Informed Treatment DecisionsStudies suggest bipolar disorder is associated with increased potential for stroke and higher odds of experiencing poor outcomes.
Latest:
Valerian: Root of All Zzz’s or Just Another Bedtime Story?Several studies on valerian have been conducted in the past 50 years for indications varying from insomnia, anxiety, restless leg syndrome, headaches, and more.
Latest:
Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial CancerTreatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
Latest:
Social Determinants of Health Matter When Treating Patients With Breast CancerPharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Latest:
Rising Use of Herbal Supplements Creates Awareness of Risks During the Perioperative PeriodPharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products.
Latest:
Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque PsoriasisTildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.
Latest:
Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer DiseaseLecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.
Latest:
Transitions of Care in Patients With Recurrent C. Diff: An Opportunity for Collaboration Among Community, Health System PharmacistsApproximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.
